ScholarIQanswers from OpenAlex
Kumamoto University Hospital
InstitutionResearch output, impact & collaborations
Kumamoto University Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Kumamoto University Hospital?
ScholarIQrecord summary
Kumamoto University Hospital is a research organisation in Kumamoto, JP. OpenAlex records 4,513 works and 182,011 citations for it. 1,072 researchers list it as their most recent affiliation.
How many works does Kumamoto University Hospital have?
ScholarIQindexed works
Kumamoto University Hospital has 4,513 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kumamoto University Hospital have?
ScholarIQcitation count
Kumamoto University Hospital has 182,011 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Kumamoto University Hospital?
ScholarIQresearcher count
Kumamoto University Hospital has 1,072 researchers in the ScholarIQ index.
What is the average h-index at Kumamoto University Hospital?
ScholarIQavg h-index
Kumamoto University Hospital has an average h-index of 71.5 in OpenAlex.
What is the ROR of Kumamoto University Hospital?
ScholarIQror
The ROR for Kumamoto University Hospital is on the source record.
What is the OpenAlex record for Kumamoto University Hospital?
ScholarIQopenalex
The OpenAlex for Kumamoto University Hospital is on the source record.
Who are the most-cited researchers behind Kumamoto University Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Kumamoto University Hospital?
ScholarIQmost cited works
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda, Shinichi Ohkawa, Hiroaki Yanagimoto, Narikazu Boku, Akira Fukutomi, Kazuya Sugimori, Hideo Baba, Kenji Yamao, T Shimamura, Masayuki Sho, Masayuki Kitano, Ann‐Lii Cheng, Kazuhiro Mizumoto, Jen‐Shi Chen, Junji Furuse, Akihiro Funakoshi, Takashi Hatori, Taketo Yamaguchi, Shinichi Egawa, Atsushi Satō, Yasuo Ohashi, Takuji Okusaka, Masao Tanaka
Effect of Matching of Class I HLA Alleles on Clinical Outcome after Transplantation of Hematopoietic Stem Cells from an Unrelated Donor
Takehiko Sasazuki, Takeo Juji, Yasuo Morishima, Naoko Kinukawa, Hidehiko Kashiwabara, Hidetoshi Inoko, Takato O. Yoshida, Akinori Kimura, Tatsuya Akaza, Nobuhiro Kamikawaji, Yoshihisa Kodera, Fumimaro Takaku, Yoshiaki Nose, Takashi Ono, Takeo Sakamaki, Shunichi Kato, Yuichi Akiyama, Shinichiro Okamoto, Hiroo Dohy, Mine Harada, Shigetaka Asano
Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tract
Ryuichi Okamoto, Tomoharu Yajima, Motomi Yamazaki, Takanori Kanai∥, Makio Mukai, Shinichiro Okamoto, Yasuo Ikeda, Toshifumi Hibi∥, Johji Inazawa, Mamoru Watanabe
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Navneet S. Majhail, J. Douglas Rizzo, Stephanie J. Lee, Mahmoud Aljurf, Yoshiko Atsuta, Carmem Bonfim, Linda J. Burns, Naeem Chaudhri, Stella M. Davies, Shinichiro Okamoto, Adriana Seber, Gèrard Socié, Jeff Szer, Maria Teresa Van Lint, John R. Wingard, André Tichelli
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim, Shunsuke Kitajima, Russell W. Jenkins, Camilla L. Christensen, Marco Campisi, Yanan Kuang, Yanxi Zhang, Evisa Gjini, Gao Zhang, Tian Tian, Debattama R. Sen, Diana Miao, Yu Imamura, Tran C. Thai, Brandon Piel, Hideki Terai, Amir Reza Aref, Timothy Hagan, Shohei Koyama, Masayuki Watanabe, Hideo Baba, Anika E. Adeni, Christine Lydon, Pablo Tamayo, Zhi Wei, Meenhard Herlyn, Thanh U. Barbie, Ravindra Uppaluri, Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie
How much of the research on Kumamoto University Hospital is open access?
ScholarIQopen access share
67%OPEN ACCESS